nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A bacterial surface-expression system using OmpA fusion-proteins.4
|
|
|
1996 |
2 |
4 |
p. 283-284 2 p. |
artikel |
2 |
Activity of monoclonal antibodies in prevention of in vitro aggregation of their antigens
|
|
|
1996 |
2 |
4 |
p. 305- 1 p. |
artikel |
3 |
Affinity maturation and structural analysis of a humanized antibody
|
|
|
1996 |
2 |
4 |
p. 276- 1 p. |
artikel |
4 |
Altered binding energetics of the M3 mutant of antibody D1.3 selected by phage display for enhanced binding to hen egg lysozyme
|
|
|
1996 |
2 |
4 |
p. 282-283 2 p. |
artikel |
5 |
A molecular model for an antibody that binds Lex and sialyl Lex
|
|
|
1996 |
2 |
4 |
p. 278- 1 p. |
artikel |
6 |
A monoclonal antibody that blocks HIV-I gp120 glycoprotein binding to neurons
|
|
|
1996 |
2 |
4 |
p. 301- 1 p. |
artikel |
7 |
An antibody against a specific peptide/MHC class I complex
|
|
|
1996 |
2 |
4 |
p. 312- 1 p. |
artikel |
8 |
An expression system for catalytic anti-bodies: characterization and applications
|
|
|
1996 |
2 |
4 |
p. 293- 1 p. |
artikel |
9 |
A novel strategy to reduce anti-idiotypic responses to campath-1
|
|
|
1996 |
2 |
4 |
p. 272-273 2 p. |
artikel |
10 |
An overview of the 1996 keystone meeting exploring and exploiting antibody and Ig superfamily combining sites
|
Huston, James S |
|
1996 |
2 |
4 |
p. 253-260 8 p. |
artikel |
11 |
Antibodies against crystals
|
|
|
1996 |
2 |
4 |
p. 289- 1 p. |
artikel |
12 |
Antibodies as modulators of protein activities — implications for intravenous therapy
|
|
|
1996 |
2 |
4 |
p. 283- 1 p. |
artikel |
13 |
Antibodies for immunosuppression and tolerance — A war analogy
|
|
|
1996 |
2 |
4 |
p. 272- 1 p. |
artikel |
14 |
Anti EGP-2 phage antibodies as a tool for identifying novel colon tumor antigens. [Abst. 223]
|
|
|
1996 |
2 |
4 |
p. 290- 1 p. |
artikel |
15 |
Antigen binding peptides derived from long random peptide phage libraries mimic antibodies and can generate mimetopes
|
|
|
1996 |
2 |
4 |
p. 297- 1 p. |
artikel |
16 |
Antigen-binding sites dominate the surface properties of antibodies
|
|
|
1996 |
2 |
4 |
p. 276- 1 p. |
artikel |
17 |
Antigen presentation of a T cell epitope inserted at different positions in an antibody heavy chain
|
|
|
1996 |
2 |
4 |
p. 305- 1 p. |
artikel |
18 |
Antimalarial antibodies produced by recombinant phage display
|
|
|
1996 |
2 |
4 |
p. 299-300 2 p. |
artikel |
19 |
Association of murine monoclonal antibody HyHEL-5 with lysozyme: biophysical characterization
|
|
|
1996 |
2 |
4 |
p. 281- 1 p. |
artikel |
20 |
Author index volume 2 (1996)
|
|
|
1996 |
2 |
4 |
p. 315-316 2 p. |
artikel |
21 |
Bacterial expression of a human Fv fragment IgM with a novel antibody combining site
|
|
|
1996 |
2 |
4 |
p. 280- 1 p. |
artikel |
22 |
B-cell superantigens: molecular, cellular and in vivo consequences
|
|
|
1996 |
2 |
4 |
p. 268-269 2 p. |
artikel |
23 |
Binary toxins for targeting cancer cells. [Abst. L01]
|
|
|
1996 |
2 |
4 |
p. 312- 1 p. |
artikel |
24 |
Binding is not enough for catalysis
|
|
|
1996 |
2 |
4 |
p. 294-295 2 p. |
artikel |
25 |
Bispecific antibody (ANTI-C3d/60.3), compensates, in vitro, for the elastase-mediated opsonin-receptor mismatch of cystic fibrosis
|
|
|
1996 |
2 |
4 |
p. 303- 1 p. |
artikel |
26 |
‘Camelising’ human VH domains for use as small recognition units. [Abst. 207]
|
|
|
1996 |
2 |
4 |
p. 285- 1 p. |
artikel |
27 |
C-CAM mediates adhesion through a homophilic domain 1/domain 1 interaction in transfected CHO cells
|
|
|
1996 |
2 |
4 |
p. 311- 1 p. |
artikel |
28 |
Cellular basis of transplant-associated arteriosclerosis in genetically altered mice
|
|
|
1996 |
2 |
4 |
p. 275- 1 p. |
artikel |
29 |
Characterisation of the binding sites of polyamine specific antibodies
|
|
|
1996 |
2 |
4 |
p. 277- 1 p. |
artikel |
30 |
Characteristics of human anti-gal genes
|
|
|
1996 |
2 |
4 |
p. 294- 1 p. |
artikel |
31 |
Characterization of anti-U1 RNA Fab isolated from bacteriophage display libraries
|
|
|
1996 |
2 |
4 |
p. 275-276 2 p. |
artikel |
32 |
Characterization of ScFv antibodies against the human TSH-receptor derived from phage display libraries
|
|
|
1996 |
2 |
4 |
p. 293-294 2 p. |
artikel |
33 |
Chimerism after organ transplantation — the mechanism of graft acceptance
|
|
|
1996 |
2 |
4 |
p. 275- 1 p. |
artikel |
34 |
Clinical imaging with a single chain Fv anti-CEA, potential for application to antibody directed enzyme prodrug therapy
|
|
|
1996 |
2 |
4 |
p. 267- 1 p. |
artikel |
35 |
Comparative protein modeling by satisfaction of spatial restraints
|
|
|
1996 |
2 |
4 |
p. 279-280 2 p. |
artikel |
36 |
Comparison of surface properties of human IgA, IgE, IgG and IgM antibodies with identical different specifities
|
|
|
1996 |
2 |
4 |
p. 282- 1 p. |
artikel |
37 |
Comparison of the N10 structural, functional and energetic epitodes of staphylococcal nuclease
|
|
|
1996 |
2 |
4 |
p. 278- 1 p. |
artikel |
38 |
Comparisons of expression in procaryotic and eucaryotic hosts of human recombinant Fab molecules
|
|
|
1996 |
2 |
4 |
p. 289- 1 p. |
artikel |
39 |
Construction of diabody phage display repertories for the selection of large numbers of bispecific antibody fragments [Abst. 217]
|
|
|
1996 |
2 |
4 |
p. 288- 1 p. |
artikel |
40 |
Crystal structure of the Vα domain of a T cell antigen receptor
|
|
|
1996 |
2 |
4 |
p. 270- 1 p. |
artikel |
41 |
Cucumber mosaic cucumovirus antibodies from a synthetic phage display library
|
|
|
1996 |
2 |
4 |
p. 296- 1 p. |
artikel |
42 |
Database-supported antibody engineering
|
|
|
1996 |
2 |
4 |
p. 304- 1 p. |
artikel |
43 |
Defective secretion of VH CDR2 mutant antibodies is characterized by increased association of the mutant heavy chains with molecular chaperones and is not a property of the light chain
|
|
|
1996 |
2 |
4 |
p. 278- 1 p. |
artikel |
44 |
Design, expression and 3-D structure of bivalent single chain Ig-like molecules. [Abst. 105]
|
|
|
1996 |
2 |
4 |
p. 276-277 2 p. |
artikel |
45 |
Design, expression, structure and immunochemistry of bivalent single chain Ig-like molecules
|
|
|
1996 |
2 |
4 |
p. 313-314 2 p. |
artikel |
46 |
Design of specifically-radiolabeled recombinant Fab: A search for Fab that bind the tumor antigens sialy-Lewisx and Thomsen-Friedenreich glycoantigens from phage display libraries
|
|
|
1996 |
2 |
4 |
p. 279- 1 p. |
artikel |
47 |
Detecting novel cell surface antigens using phage antibody display
|
|
|
1996 |
2 |
4 |
p. 302- 1 p. |
artikel |
48 |
Development of methodologies for the expression of soluble T-cell receptors (TCR)
|
|
|
1996 |
2 |
4 |
p. 308- 1 p. |
artikel |
49 |
Display OFT-cell receptors on filamentous phage. [Abst. 409]
|
|
|
1996 |
2 |
4 |
p. 310-311 2 p. |
artikel |
50 |
Effects of mutations in the heavy chain CDR3 region on the affinity of an anti-PSA diabody
|
|
|
1996 |
2 |
4 |
p. 280-281 2 p. |
artikel |
51 |
Engineering antibodies for tumor targeting using phage display
|
|
|
1996 |
2 |
4 |
p. 290-291 2 p. |
artikel |
52 |
Engineering of anti-digoxin anybody combining sites
|
|
|
1996 |
2 |
4 |
p. 263-264 2 p. |
artikel |
53 |
Engineering scFvs and kinetic analysis of binding affinity on the BIAcoreTM
|
|
|
1996 |
2 |
4 |
p. 277-278 2 p. |
artikel |
54 |
Engineering the antibody combining site for high affinity binding
|
|
|
1996 |
2 |
4 |
p. 264- 1 p. |
artikel |
55 |
Enhancing the tumor-specifity of human T cells by the expression of chimeric immunoglobulin/T cell receptor genes
|
|
|
1996 |
2 |
4 |
p. 303-304 2 p. |
artikel |
56 |
Eukaryotic expression vectors for the membrane display of single-chain antibodies: their use in the selection of transiently-transfected cells from total populations in culture
|
|
|
1996 |
2 |
4 |
p. 297-298 2 p. |
artikel |
57 |
Evaluation of different single chain constructs based on antineuroblastoma mab chCE7
|
|
|
1996 |
2 |
4 |
p. 304- 1 p. |
artikel |
58 |
Evidence for distinct contributions of heavy and light chains to the restriction of antibody recognition of the human immunodeficiency virus type-1 principal neutralization determinant
|
|
|
1996 |
2 |
4 |
p. 306-307 2 p. |
artikel |
59 |
Exploring and exploiting the anti-tumor monoclonal antibody BR96
|
|
|
1996 |
2 |
4 |
p. 264- 1 p. |
artikel |
60 |
Expression of soluble T-cell receptor — leucine zipper fusions
|
|
|
1996 |
2 |
4 |
p. 309- 1 p. |
artikel |
61 |
Fine tuning of an antibody binding site by mutagenesis and phage display
|
|
|
1996 |
2 |
4 |
p. 286-287 2 p. |
artikel |
62 |
Fv fragment crystal structures of the antibody B1-8 in unliganded form and with bound hapten NIP-CAP; analysis at 2 Å resolution. [Abst. 119]
|
|
|
1996 |
2 |
4 |
p. 281- 1 p. |
artikel |
63 |
General features of antibody crystal structures
|
|
|
1996 |
2 |
4 |
p. 261- 1 p. |
artikel |
64 |
Generation of a humanized anti-CD40 mab for treatment of autoimmune diseases
|
|
|
1996 |
2 |
4 |
p. 299- 1 p. |
artikel |
65 |
Generation of an estradiol specific anti-body by phage display
|
|
|
1996 |
2 |
4 |
p. 291-292 2 p. |
artikel |
66 |
Generation of polyclonal and monoclonal catalytic sheep antibodies
|
|
|
1996 |
2 |
4 |
p. 288- 1 p. |
artikel |
67 |
Generation of scFv immunotoxin molecules based on anti-B7.1/2 mabs for the treatment of Hodgkin's disease
|
|
|
1996 |
2 |
4 |
p. 298- 1 p. |
artikel |
68 |
Generation of synthetic and lymphocyte-derived antibody libraries
|
|
|
1996 |
2 |
4 |
p. 265- 1 p. |
artikel |
69 |
Genetically engineered lipid-tagged antibody; use in liposome-based fluoroimmunoassay
|
|
|
1996 |
2 |
4 |
p. 301-302 2 p. |
artikel |
70 |
Global changes in amide hydrogen exchange rates for a protein antigen in complex with three different antibodies
|
|
|
1996 |
2 |
4 |
p. 281-282 2 p. |
artikel |
71 |
High affinity antibodies against 3-FL (Lex, CD15) from a phage display library
|
|
|
1996 |
2 |
4 |
p. 313- 1 p. |
artikel |
72 |
High-affinity recombinant antibodies against neovasculature and extra-cellular matrix antigens
|
|
|
1996 |
2 |
4 |
p. 267-268 2 p. |
artikel |
73 |
Human antibodies specific for human TGF-β derived from phage display libraries
|
|
|
1996 |
2 |
4 |
p. 306- 1 p. |
artikel |
74 |
Human antibody diversity
|
|
|
1996 |
2 |
4 |
p. 263- 1 p. |
artikel |
75 |
Humanization of murine 6G425: An anti-IL-8 monoclonal antibody which blocks binding of IL-8 to human neutrophils
|
|
|
1996 |
2 |
4 |
p. 286- 1 p. |
artikel |
76 |
Idiotypes as vaccines for the treatment of B-cell malignancies
|
|
|
1996 |
2 |
4 |
p. 268- 1 p. |
artikel |
77 |
Immunoconjugates for therapy of carcinomas
|
|
|
1996 |
2 |
4 |
p. 273- 1 p. |
artikel |
78 |
Immunoglobulins and T cell receptors in inflammatory bowel disease
|
|
|
1996 |
2 |
4 |
p. 306- 1 p. |
artikel |
79 |
Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity
|
Ressing, Maaike E |
|
1996 |
2 |
4 |
p. 241-251 11 p. |
artikel |
80 |
Implications and applications of monogamous and crosslinking multivalent antibody binding
|
|
|
1996 |
2 |
4 |
p. 312- 1 p. |
artikel |
81 |
Induction of anti-carbohydrate immune responses by carbohydrate mimicking peptides
|
|
|
1996 |
2 |
4 |
p. 309-310 2 p. |
artikel |
82 |
Influence of affinity, avidity and size on the tumor retention of anti-c-erB-2 single-chain Fv molecules. [Abst. 300]
|
|
|
1996 |
2 |
4 |
p. 296- 1 p. |
artikel |
83 |
Inhibition of cyclin D1 oncogene with intracellular single chain antibodies
|
|
|
1996 |
2 |
4 |
p. 304-305 2 p. |
artikel |
84 |
Interactions of recombinant Fab with nucleic acid: binding properties and role of heavy chain CDRS
|
|
|
1996 |
2 |
4 |
p. 287- 1 p. |
artikel |
85 |
Intracellular antibodies (intrabodies): development and gene therapy potential
|
|
|
1996 |
2 |
4 |
p. 268- 1 p. |
artikel |
86 |
Intracellular (PL) antibodies for virus immunotherapy in transgenic plants. [Abst. 304]
|
|
|
1996 |
2 |
4 |
p. 297- 1 p. |
artikel |
87 |
Intracellular targeting by anti-p21 ras scFv: A model for anti-tumor therapy. [Abst. 333]
|
|
|
1996 |
2 |
4 |
p. 306- 1 p. |
artikel |
88 |
In vitro selection of a high affinity anti-oestradiol antibody using a phage display human antibody library
|
|
|
1996 |
2 |
4 |
p. 289-290 2 p. |
artikel |
89 |
In vivo expression of recombinant anti-tumor immunoglobulin-IL-2 fusion protein
|
|
|
1996 |
2 |
4 |
p. 301- 1 p. |
artikel |
90 |
In vivo selection of a lupus phage-display Fv library
|
|
|
1996 |
2 |
4 |
p. 295-296 2 p. |
artikel |
91 |
Isolated Ig superfamily domain units: MHC and beyond
|
|
|
1996 |
2 |
4 |
p. 271-272 2 p. |
artikel |
92 |
Isolation and characterization of antibody fragments directed to disease markers isolated from patient derived combinatorial libraries
|
|
|
1996 |
2 |
4 |
p. 287- 1 p. |
artikel |
93 |
Isolation and characterization of human single chain Fv (scFv) against botulinum neurotoxin type A
|
|
|
1996 |
2 |
4 |
p. 283- 1 p. |
artikel |
94 |
Isolation and partial characterization of human antibody fragments specific for group B Streptococcal (GBS) type III capsular polysaccharide isolated by phage display
|
|
|
1996 |
2 |
4 |
p. 285- 1 p. |
artikel |
95 |
Isolation of cross-reactive anti-tetanus and anti-melittin antibodies by phage display
|
|
|
1996 |
2 |
4 |
p. 294- 1 p. |
artikel |
96 |
Isolation of high affinity and specificity testosterone binding antibodies from a phage display library
|
|
|
1996 |
2 |
4 |
p. 292-293 2 p. |
artikel |
97 |
Isolation of human antibodies with sub-nanomolar affinities directly from a large non-immunized phage display library
|
|
|
1996 |
2 |
4 |
p. 294- 1 p. |
artikel |
98 |
Isolation of novel tumor antigens using antibody phage display
|
|
|
1996 |
2 |
4 |
p. 288-289 2 p. |
artikel |
99 |
Leucine zipper dimerized bivalent and bispecific SCFV antibodies from a phage display library. [Abst. 308]
|
|
|
1996 |
2 |
4 |
p. 298-299 2 p. |
artikel |
100 |
Macaque anti-human antibodies: analysis of the host response to a therapeutic humanized antibody
|
|
|
1996 |
2 |
4 |
p. 300-301 2 p. |
artikel |
101 |
Mammalian expression and characterization of a dimeric single chain antibody specific for integrin avβ3
|
|
|
1996 |
2 |
4 |
p. 297- 1 p. |
artikel |
102 |
Molecular analysis of the function of the human IGA FC domain
|
|
|
1996 |
2 |
4 |
p. 308-309 2 p. |
artikel |
103 |
Molecular basis of antigen mimicry by an anti-idiotopic antibody
|
|
|
1996 |
2 |
4 |
p. 263- 1 p. |
artikel |
104 |
Molecular characterization of the antigen binding domain of a human natural anti-F(ab′)2 auto-antibody
|
|
|
1996 |
2 |
4 |
p. 295- 1 p. |
artikel |
105 |
Molecular recognition of antigen involves CD4/MHC class II/TCR lattice formation on the surface of helper T lymphocytes
|
|
|
1996 |
2 |
4 |
p. 271- 1 p. |
artikel |
106 |
Monoclonal antibodies to a seminoma specific antigen
|
|
|
1996 |
2 |
4 |
p. 303- 1 p. |
artikel |
107 |
Monoclonal antibodies to fimbriae inhibit proteusmirabilis attachment and invasion in vitro
|
|
|
1996 |
2 |
4 |
p. 296-297 2 p. |
artikel |
108 |
Multicombinatorial libraries: new vectors and easy access to very large repertories
|
|
|
1996 |
2 |
4 |
p. 292- 1 p. |
artikel |
109 |
Novel immunogen structures and immunization strategies induce antibodies to conserved epitopes of cannabinoids
|
|
|
1996 |
2 |
4 |
p. 290- 1 p. |
artikel |
110 |
Nuclear localization of autoantibodies: novel insights into protein translocation and cellular function
|
|
|
1996 |
2 |
4 |
p. 302-303 2 p. |
artikel |
111 |
Oligosaccharide epitopes and antibody binding sites of Fab and single chain Fv molecules
|
|
|
1996 |
2 |
4 |
p. 262- 1 p. |
artikel |
112 |
Optimisation of the design of recombinant single-chain Fv fragments of antibody molecules
|
|
|
1996 |
2 |
4 |
p. 267- 1 p. |
artikel |
113 |
Optimization of catalysis and cytotoxicity
|
|
|
1996 |
2 |
4 |
p. 266- 1 p. |
artikel |
114 |
Polyreactive immunoglobulins display diversity in binding site topology
|
|
|
1996 |
2 |
4 |
p. 279- 1 p. |
artikel |
115 |
Preclinical development of huNR-LU-10, a humanized antibody for tumor targeting
|
|
|
1996 |
2 |
4 |
p. 300- 1 p. |
artikel |
116 |
Preclinical models for targeted therapy
|
|
|
1996 |
2 |
4 |
p. 266- 1 p. |
artikel |
117 |
Production and characterization of novel tetravalent bispecific antibodies
|
|
|
1996 |
2 |
4 |
p. 298- 1 p. |
artikel |
118 |
Properties of scFv proteins exhibiting specific binding to the plant enzyme enoyl acyl carrier portein reductase
|
|
|
1996 |
2 |
4 |
p. 293- 1 p. |
artikel |
119 |
Protein engineering: redesigning of the antibody combining site
|
|
|
1996 |
2 |
4 |
p. 291- 1 p. |
artikel |
120 |
Radiochemistry in antibody targeting
|
|
|
1996 |
2 |
4 |
p. 265-266 2 p. |
artikel |
121 |
Radioimmunotherapy after chemotherapy compared to chemotherapy alone in the treatment of advanced ovarian cancer: a matched analysis
|
|
|
1996 |
2 |
4 |
p. 272- 1 p. |
artikel |
122 |
Rational modification of antibodies and T-cell receptors
|
|
|
1996 |
2 |
4 |
p. 269- 1 p. |
artikel |
123 |
Rational mutation of a catalytic antibody
|
|
|
1996 |
2 |
4 |
p. 291- 1 p. |
artikel |
124 |
Recombinant forms of a T-cell specific IGM
|
|
|
1996 |
2 |
4 |
p. 309- 1 p. |
artikel |
125 |
Recombinant human antibodies against the Plasmodium falciparum glutamate rich protein
|
|
|
1996 |
2 |
4 |
p. 299- 1 p. |
artikel |
126 |
Recombinant human HLA-DR1 class II MHC molecules as biologically active covalently-linked heterotrimers of antigenic peptide, beta chain and alpha chain
|
|
|
1996 |
2 |
4 |
p. 310- 1 p. |
artikel |
127 |
Recombinant TNF-B1 (Fv) fusion protein selectively kills LEY-antigen expressing TNF-α sensitive human cancer cells
|
|
|
1996 |
2 |
4 |
p. 305- 1 p. |
artikel |
128 |
Redirected cellular cytotoxicity mediated by bispecific antibodies
|
|
|
1996 |
2 |
4 |
p. 266- 1 p. |
artikel |
129 |
Remodeling of a catalytic antibody through mutagenesis and selection
|
|
|
1996 |
2 |
4 |
p. 266-267 2 p. |
artikel |
130 |
Residues near the amino termini contribute to hapten recognition in a cloned anti-17β-estradiol Fab fragment
|
|
|
1996 |
2 |
4 |
p. 280- 1 p. |
artikel |
131 |
R/K residues located in the middle positions of peptide where side chains protrude towards the solvent may directly prevent HLA-A11 specific antibody, AUF5.13, from binding to the complexes
|
|
|
1996 |
2 |
4 |
p. 311-312 2 p. |
artikel |
132 |
Role of chain pairing and peptide occupancy for the production of functional soluble IA MHC class II molecules
|
|
|
1996 |
2 |
4 |
p. 311- 1 p. |
artikel |
133 |
Role of junctional diversity in anti-DNA antibodies
|
|
|
1996 |
2 |
4 |
p. 279- 1 p. |
artikel |
134 |
SCFV antibody fragments for breast tumor targeting
|
|
|
1996 |
2 |
4 |
p. 285- 1 p. |
artikel |
135 |
scFv-kappa: A new single-chain antibody format showing increased expression levels in both procaryotic and eucaryotic systems
|
|
|
1996 |
2 |
4 |
p. 286- 1 p. |
artikel |
136 |
Selected light chains combine with a given heavy chain to confer anti-M or -N specificity
|
|
|
1996 |
2 |
4 |
p. 292- 1 p. |
artikel |
137 |
Selection of bivalent anti-PSA antibody clones from a phage display library
|
|
|
1996 |
2 |
4 |
p. 302- 1 p. |
artikel |
138 |
Selection of SCFV fragments against oxygen sensitive reduced flavin
|
|
|
1996 |
2 |
4 |
p. 284- 1 p. |
artikel |
139 |
Single chain Fv cytokine fusion proteins as vaccines for B cell lymphoma
|
|
|
1996 |
2 |
4 |
p. 300- 1 p. |
artikel |
140 |
Single-chain Fv immunotechnology
|
|
|
1996 |
2 |
4 |
p. 269-270 2 p. |
artikel |
141 |
Single-chain immunofusions engineered with human RNases
|
|
|
1996 |
2 |
4 |
p. 313- 1 p. |
artikel |
142 |
Single-chain immunotoxins for the treatment of carcinomas and hematologic malignancies
|
|
|
1996 |
2 |
4 |
p. 274- 1 p. |
artikel |
143 |
Stabilization of a single-chain FV antibody by introduction of a disulfide bond. [Abst. 338]
|
|
|
1996 |
2 |
4 |
p. 307-308 2 p. |
artikel |
144 |
Structure of a humanized anti-lysozyme FV domain. [Abst. 103]
|
|
|
1996 |
2 |
4 |
p. 276- 1 p. |
artikel |
145 |
Structures of catalytic and anti-peptide antibody binding sites
|
|
|
1996 |
2 |
4 |
p. 261-262 2 p. |
artikel |
146 |
Studies of a phage-derived anti-CEA SCFV obtained fron a combinatorial library
|
|
|
1996 |
2 |
4 |
p. 265- 1 p. |
artikel |
147 |
Studies on the interaction of the small organic pesticide molecule atrazine with single-chain antibody fragments
|
|
|
1996 |
2 |
4 |
p. 286- 1 p. |
artikel |
148 |
Subject index volume 2 (1996)
|
|
|
1996 |
2 |
4 |
p. 317-318 2 p. |
artikel |
149 |
Targeting adenovirus-mediated gene delivery with recombinant antibodies
|
|
|
1996 |
2 |
4 |
p. 307- 1 p. |
artikel |
150 |
T cell receptor interactions with photoreactive H-2KDd peptide derivative complexes
|
|
|
1996 |
2 |
4 |
p. 310- 1 p. |
artikel |
151 |
Testing of an experimentally supported peptid-Fab-model by site-directed mutagenesis
|
|
|
1996 |
2 |
4 |
p. 282- 1 p. |
artikel |
152 |
The analysis of anti-self and antimicrobial antibodies from a patient with SLE obtained from a combinatorial library
|
|
|
1996 |
2 |
4 |
p. 287-288 2 p. |
artikel |
153 |
The complete nucleotide sequence of the human immunoglobulin D Segment Locus. [Abst. 100]
|
|
|
1996 |
2 |
4 |
p. 275- 1 p. |
artikel |
154 |
The development of recombinant toxins for the treatment of cancer
|
|
|
1996 |
2 |
4 |
p. 273-274 2 p. |
artikel |
155 |
The development of the interdomain interface as the recognition structure for FC receptor Ig interaction
|
|
|
1996 |
2 |
4 |
p. 309- 1 p. |
artikel |
156 |
The folding pathway of antibodies: in vitro studies by NMR, engineering and selection for better folding
|
|
|
1996 |
2 |
4 |
p. 269- 1 p. |
artikel |
157 |
The generation of polyurethane-specific catalytic antibodies
|
|
|
1996 |
2 |
4 |
p. 292- 1 p. |
artikel |
158 |
The glycosylated adhesion domain of human CD2: glycan structure and significance for the interaction with CD58
|
|
|
1996 |
2 |
4 |
p. 262-263 2 p. |
artikel |
159 |
The role of IGG glycosylation in rheumatoid factor (RF) recognition
|
|
|
1996 |
2 |
4 |
p. 308- 1 p. |
artikel |
160 |
The structure and antigen specificity of antibody binding sites can be influenced by clan-specific and family-specific amino acids in heavy chain frameworks 1 and 3. [Abst. 107]
|
|
|
1996 |
2 |
4 |
p. 277- 1 p. |
artikel |
161 |
The use of antibody fragments for the sensitive detection and removal of organic pollutants from the environment. [Abst. 337]
|
|
|
1996 |
2 |
4 |
p. 307- 1 p. |
artikel |
162 |
Towards sequence-specific antibody proteases: a sensitive assay for peptide-bond hydrolysis
|
|
|
1996 |
2 |
4 |
p. 284- 1 p. |
artikel |
163 |
Transplantation without immunosuppression
|
|
|
1996 |
2 |
4 |
p. 274- 1 p. |
artikel |
164 |
Using multiple loxP sites to access antibody heaby-light chain combinatorial diversity
|
|
|
1996 |
2 |
4 |
p. 295- 1 p. |
artikel |
165 |
Using multiple loxP sites to access antibody heavy-light chain combinatorial diversity
|
|
|
1996 |
2 |
4 |
p. 264-265 2 p. |
artikel |
166 |
Utilization of the genetic and structural information on MHC molecules to study autoimmunity and alloreactivity
|
|
|
1996 |
2 |
4 |
p. 270-271 2 p. |
artikel |
167 |
Volume contents volume 2 (1996)
|
|
|
1996 |
2 |
4 |
p. 319-320 2 p. |
artikel |
168 |
Why are immune reactions to allografts so aggressive?
|
|
|
1996 |
2 |
4 |
p. 270- 1 p. |
artikel |
169 |
Yeast surface display system for antibody engineering
|
|
|
1996 |
2 |
4 |
p. 283- 1 p. |
artikel |